Curebase, Inc. announced that it has received $40.000011 million in funding from a group of investors

On May 5, 2022, Curebase, Inc. closed the transaction. The round of funding led by new investor Industry Ventures, L.L.C. The transaction included participation from new investors, aCrew Capital, Wil LLC, Positive Sum Advisors, Gilead Sciences, Inc., and Gaingels, LLC, existing investors GGV Capital, LLC, Bold Capital Partners, and Xfund Management Company, LLC.